Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jacob P. Laubach
Incidence and Clinical Features of Extramedullary Multiple Myeloma in Patients Who Underwent Stem Cell Transplantation
Blood
Biochemistry
Immunology
Cell Biology
Hematology
A Phase 1/2 Study of Evofosfamide, a Hypoxia-Activated Prodrug With or Without Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Daratumumab-Based Regimens Are Highly Effective and Well Tolerated in Relapsed or Refractory Multiple Myeloma Regardless of Patient Age: Subgroup Analysis of the Phase 3 CASTOR and POLLUX Studies
Haematologica
Hematology
Impact of Concomitant Dexamethasone Dosing Schedule on Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma
British Journal of Haematology
Hematology
Investigational Agents in Immunotherapy: A New Horizon for the Treatment of Multiple Myeloma
British Journal of Haematology
Hematology
Enduring Efficacy and Tolerability of Daratumumab in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma ( GEN 503): Final Results of an Open‐label, Phase 1/2 Study
British Journal of Haematology
Hematology
The Medical Research Council Myeloma IX Trial: The Impact on Treatment Paradigms*
European Journal of Haematology
Medicine
Hematology
The Impact of ASCT on Patients With Newly Diagnosed Multiple Myeloma Who Receive RVD Induction
Journal of Hematological Malignancies
Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
Seminars in Hematology
Hematology
